drugset / Trial / NCT00260988

A Comparison of Dalteparin and Tinzaparin for Prevention of Blood Clots in Hemodialysis Patients on Oral Anticoagulants Having Surgery

NCT00260988

RandomizedParallel-groupOpen-labelPrevention

Summary

The purpose of this study is to better understand if either dalteparin or tinzaparin is a better drug to use in dialysis patients on blood thinners who are at high risk of developing blood clots and need surgery.

Timeline

Start
2003-10
Primary completion
2008-11
Completion
2008-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dalteparin sodium Other / unclassified 5000 iu Subcutaneous
Comparator Tinzaparin Other / unclassified 4500 iu Subcutaneous

Indications